Sfoglia per AUTORE
CARLI G
Collezione AOU Novara

  

Items : 9

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes. in Annals of hematology / Ann Hematol. 2024 Feb;103(2):437-442. doi: 10.1007/s00277-023-05577-9. Epub 2023 Dec 7.

2024
AOU Novara
AOU Città della Salute di Torino

Bellini M; Finazzi MC; Rambaldi A; Tognoni G; Cattaneo D; Vianelli N; Scaffidi L; Bucelli C; Lunghi F; Ramundo F; Betti S; Gesullo F; Guglielmelli P; Calabresi L; Loscocco GG; Cacciola E; Cascavilla N; Mora B; Rumi E; Patriarca A; Siragusa S; Rapezzi D; Musolino C; Caramella M; Pane F; Ricco A; Carli G; Palandri F; Benevolo G; et alii...

Breakthrough infections in MPN-COVID vaccinated patients. in Blood cancer journal / Blood Cancer J. 2022 Nov 15;12(11):154. doi: 10.1038/s41408-022-00749-8.

2022
AOU Novara
AOU Città della Salute di Torino
AO Alessandria

Vannucchi AM; Rambaldi A; Benajiba L; Carbonell S; Kulikowska de Na??cz A; Cattaneo D; Bucelli C; Betti S; Curto-Garcia N; Cavalca F; Borsani O; Guenova M; Navas Elorza B; Angona A; Cichocka E; Lopez Abadia E; Carli G; Xicoy Cirici B; Kusec R; Sagues Serrano M; Garcia-Gutierrez V; Sanchez AM; Hernandez-Boluda JC; Griesshammer M; Kiladjian JJ; Bolaños Calderón E; Heidel FH; Magro Mazo E; Quiroz Cervantes K; et alii...

Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19. in American journal of hematology / Am J Hematol. 2022 Dec;97(12):E470-E473. doi: 10.1002/ajh.26732. Epub 2022 Sep 27.

2022
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Vannucchi AM; Rambaldi A; Curto-Garcia N; Cavalca F; Bellini M; Betti S; Borsani O; de Na??cz AK; Cattaneo D; Bucelli C; Cichocka E; Koschmieder S; Lopez Abadia E; Kusec R; Xicoy Cirici B; Angona A; Navas Elorza B; Sagues Serrano M; Carreno-Tarragona G; Osorio S; Carli G; Hernandez-Boluda JC; Garcia-Gutierrez V; Marin Sanchez A; Magro Mazo E; Griesshammer M; Quiroz Cervantes K; Bolaños Calderón E; Patriarca A; et alii...

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Mar;8(3):e175-e184. doi: 10.1016/S2352-3026(20)30373-2. Epub 2021 Jan 18.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Tognoni G; Finazzi MC; Bellini M; Bucelli C; Lunghi F; Vianelli N; Scaffidi L; Betti S; Guglielmelli P; Loscocco GG; Mora B; Cacciola E; Mannarelli C; Patriarca A; Cascavilla N; Rumi E; Siragusa S; Musolino C; Caramella M; Rapezzi D; Ricco A; Carli G; Palandri F; Pane F; Benevolo G; Bonifacio M; Iurlo A; Ciceri F; Ghirardi A; et alii...

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. in Blood cancer journal / Blood Cancer J. 2021 Feb 4;11(2):21. doi: 10.1038/s41408-021-00417-3.

2021
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Vannucchi AM; Betti S; Harrison C; Curto-Garcia N; Cavalca F; Bellini M; Benajiba L; Bellosillo B; Garrote M; Cattaneo D; Daffini R; Guglielmelli P; Cirici BX; Abadia EL; Carli G; Cuevas B; Hernandez-Boluda JC; Koschmieder S; Angona A; Mazo EM; Lunghi F; Patriarca A; Elorza BN; Serrano MS; Carreno-Tarragona G; Sobas MA; Bonifacio M; Cervantes KSQ; et alii...

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia. in Blood / Blood. 2021 Aug 19;138(7):571-583. doi: 10.1182/blood.2021010735.

2021
AOU Città della Salute di Torino
AOU Novara

Vianelli N; Zaja F; De Stefano V; Rodeghiero F; Mazzucconi MG; Cavo M; Sutto E; Carpenedo M; Carli G; Nicolosi D; Baldacci E; Auteri G; Borchiellini A; Giuffrida G; Caocci G; Chiurazzi F; Consoli U; Cantoni S; Oliva EN; Barcellini W; Patriarca A; Rivolti E; Carrai V; Bartoletti D; Ferretti A; Ruggeri M; Lucchini E; Palandri F; Rossi E; et alii...

Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study. in British journal of haematology / Br J Haematol. 2021 Apr;193(2):386-396. doi: 10.1111/bjh.17334. Epub 2021 Feb 22.

2021
AOU Città della Salute di Torino
AOU Novara

Zaja F; Fanin R; Rodeghiero F; Carpenedo M; Giardini I; Gigliotti CL; Boggio E; Dianzani U; Crea E; Vignetti M; Paoloni F; Santoro C; Barcellini W; Celli M; Consoli U; Valeri F; Carli G; Patriarca A; Rossi E; Auteri G; Vianelli N; Volpetti S; Palandri F; Lucchini E;

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. in Blood / Blood. 2020 Jan 30;135(5):381-386. doi: 10.1182/blood.2019002614.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Di Veroli A; Vannucchi AM; Barbui T; Rambaldi A; Griesshammer M; Alvarez-Larran A; Isfort S; Marchetti M; McMullin MF; Tieghi A; Recasens V; Carli G; Cacciola R; Benevolo G; Fox ML; Beggiato E; Lunghi F; Angona A; Wille K; Perez-Encinas M; Erez D; Gomez M; Rapezzi D; Palova M; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; et alii...

MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL). in HemaSphere / Hemasphere. 2019 Oct 22;3(6):e305. doi: 10.1097/HS9.0000000000000305. eCollection 2019 Dec.

2019
ASL Torino 4
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Zaja F; Visco C; Loseto G; Mazzone AM; Olivieri J; Nassi L; Piazza F; Fama A; Giannoccaro M; Greco A; Di Rocco A; Tomei G; Sgherza N; Mansueto G; Gini G; Mosna F; Finolezzi E; Calimeri T; Di Napoli A; Zanni M; Zilioli VR; Flenghi L; Romano A; Pelosini M; Marino D; Balzarotti M; Rattotti S; Stefani PM; Novo M; et alii...